SEC Filing Summary: Ra Medical Systems, Inc. (RMED)
Business Context and Reporting Period
This Form 8-K Current Report was filed by Ra Medical Systems, Inc. on July 7, 2023, covering events occurring on July 3, 2023. The registrant is a Delaware corporation with principal executive offices in Fort Mill, SC, and its common stock trades on the NYSE American under the symbol RMED. The company is designated as an emerging growth company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a specific corporate action regarding equity securities rather than periodic financial performance.
Material Changes
The primary material change reported is the unregistered sale of equity securities under Item 3.02. Specifically:
- On July 3, 2023, the Company converted 1,750 shares of outstanding Series A Convertible Preferred Stock.
- This conversion resulted in the issuance of 1,093,552 shares of common stock.
- The transaction occurred in two separate conversions of 875 preferred shares each, yielding 546,776 common shares per conversion.
- The conversion rate was approximately 625 common shares for each share of Series A Convertible Preferred Stock.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, or outlook for future periods. The transaction was executed pursuant to the exemption contained in Section 3(a)(9) of the Securities Act of 1933, as it involved an exchange with existing security holders without the payment of commission or remuneration. The issued shares have been registered for resale on an effective Form S-3 registration statement.
Investor Verification Checklist
- Verify the total number of common shares outstanding post-conversion to assess dilution impact.
- Confirm the status of the Form S-3 registration statement for the resale of the newly issued shares.
- Review the terms of the Series A Convertible Preferred Stock to understand remaining conversion obligations.
- Check subsequent filings for any changes in the company's capital structure or cash position resulting from this conversion.